Presently, Hervé Hoppenot holds the position of Chairman, President & Chief Executive Officer at Incyte Corp.

He is also on the board of Biotechnology Innovation Organization, Cellectis SA and Pharmaceutical Research & Manufacturers of America.

He previously held the position of President for Novartis Pharmaceuticals Corp., President at Novartis Oncology, Inc., Head-US Oncology Business Unit at Aventis SA, Vice President-Oncology Division at Aventis Pharmaceuticals, Inc., Principal at Rhone Poulenc AG, Inc., Head-Product Strategy & Scientific Development at Novartis Pharmaceuticals Corp. and Head-US Oncology Business Unit at Rhone-Poulenc Rorer Pharmaceuticals, Inc.